Article
Pericyte phenotype switching alleviates immunosuppression and sensitizes vascularized tumors to immunotherapy in preclinical models.
The Journal of clinical investigation - 17 Sept 2024
Li Zhi-Jie, He Bo, Domenichini Alice, Satiaputra Jiulia, Wood Kira H, Lakhiani Devina D, Bashaw Abate A, Nilsson Lisa M, Li Ji, Bastow Edward R, Johansson-Percival Anna, Denisenko Elena, Forrest Alistair Rr, Sakaram Suraj, Carretero Rafael, Hämmerling Günter J, Nilsson Jonas A, Lee Gabriel Yf, Ganss Ruth
Abstract excerpt
T cell-based immunotherapies are a promising therapeutic approach for multiple malignancies, but their efficacy is limited by tumor hypoxia arising from dysfunctional blood vessels. Here, we report that cell-intrinsic properties of a single vascular component, namely the pericyte, contribute to the control of tumor oxygenation, macrophage polarization, vessel inflammation, and T cell infiltration. Switching...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
